The present invention pertains to novel dibenzo[b,f]oxepine-10-carboxamides compound to a process for the preparation of such compounds of formula I, their use as a pharmaceuticals, especially in the treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation, and to pharmaceutical compositions and combinations comprising such compounds of formula I.

 
Web www.patentalert.com

< Method for identifying agents that interact with beta-site APP cleaving enzyme (BACE)

> Glycine transporter-1 inhibitors

> Method of screening an antibody for activity in clearing an amyloid deposit

~ 00558